Hillsdale Investment Management Inc. Bausch Health Companies Inc. Transaction History

Hillsdale Investment Management Inc.

$1.13 Billion
Q1 2024

A detailed history of Hillsdale Investment Management Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 3,409,383 shares of BHC stock, worth $23.8 Million. This represents 3.19% of its overall portfolio holdings.

Number of Shares

3,409,383

Previous 296,260 1050.81%

Holding current value

$23.8 Million

Previous $2.38 Million 1422.43%

% of portfolio

3.19%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$7.77 - $10.61 $24.2 Million - $33 Million	3,113,123 Added 1050.81%	3,409,383 $36.2 Million
Q4 2023 Feb 09, 2024	BUY	$6.53 - $8.23 $1.52 Million - $1.91 Million	232,160 Added 362.18%	296,260 $2.38 Million
Q3 2023 Nov 09, 2023	BUY	$7.69 - $9.71 $492,929 - $622,411	64,100 New	64,100 $526,000
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $7,060 - $23,630	-1,000 Reduced 50.0%	1,000 $8,000
Q1 2022 Apr 28, 2022	SELL	$21.6 - $27.79 $82,080 - $105,602	-3,800 Reduced 65.52%	2,000 $46,000

Q4 2021 Feb 07, 2022	SELL	$23.0 - $29.01 $477,250 - $601,957	-20,750 Reduced 78.15%	5,800 $160,000
Q3 2021 Oct 21, 2021	BUY	$25.04 - $30.06 $30,048 - $36,072	1,200 Added 4.73%	26,550 $740,000
Q2 2021 Jul 29, 2021	SELL	$27.43 - $32.7 $7.13 Million - $8.5 Million	-259,850 Reduced 91.11%	25,350 $743,000
Q1 2021 Apr 22, 2021	BUY	$21.37 - $34.38 $6.03 Million - $9.7 Million	282,200 Added 9406.67%	285,200 $9.05 Million
Q4 2020 Feb 09, 2021	BUY	$15.31 - $21.12 $22,965 - $31,680	1,500 Added 100.0%	3,000 $62,000
Q3 2020 Nov 13, 2020	SELL	$14.88 - $20.13 $75,888 - $102,663	-5,100 Reduced 77.27%	1,500 $23,000
Q2 2020 Aug 11, 2020	BUY	$13.31 - $20.51 $31,944 - $49,224	2,400 Added 57.14%	6,600 $120,000
Q1 2020 May 12, 2020	SELL	$12.98 - $30.25 $3.75 Million - $8.73 Million	-288,600 Reduced 98.57%	4,200 $65,000
Q4 2019 Feb 12, 2020	SELL	$18.89 - $31.89 $1.24 Million - $2.09 Million	-65,400 Reduced 18.26%	292,800 $8.74 Million
Q3 2019 Nov 13, 2019	BUY	$20.88 - $25.66 $361,224 - $443,918	17,300 Added 5.07%	358,200 $7.82 Million
Q2 2019 Aug 02, 2019	BUY	$20.52 - $26.45 $153,900 - $198,375	7,500 Added 2.25%	340,900 $8.59 Million
Q1 2019 May 13, 2019	BUY	$20.23 - $26.29 $445,060 - $578,380	22,000 Added 7.06%	333,400 $8.24 Million
Q4 2018 Feb 12, 2019	BUY	$17.64 - $28.32 $3.01 Million - $4.84 Million	170,800 Added 121.48%	311,400 $5.77 Million
Q3 2018 Nov 09, 2018	SELL	$20.64 - $25.67 $9.55 Million - $11.9 Million	-462,500 Reduced 76.69%	140,600 $3.61 Million
Q2 2018 Aug 13, 2018	BUY	$15.07 - $26.86 $9.09 Million - $16.2 Million	603,100 New	603,100 $14 Million

Others Institutions Holding BHC

# of Institutions

281

Shares Held

278M

Call Options Held

21.5M

Put Options Held

21.8M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.52B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Account

Hillsdale Investment Management Inc. Bausch Health Companies Inc. Transaction History